TY - JOUR
T1 - Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence
T2 - A propensity score analysis
AU - Yoshida, A.
AU - Takahashi, O.
AU - Okumura, Y.
AU - Arima, N.
AU - Nakatsukasa, K.
AU - Tanabe, M.
AU - Shien, T.
AU - Masuda, N.
AU - Tanaka, S.
AU - Komoike, Y.
AU - Taguchi, T.
AU - Iwase, T.
AU - Nishimura, R.
AU - Inaji, H.
AU - Yamauchi, H.
AU - Ishitobi, M.
N1 - Funding Information:
This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Breast Cancer Society and the Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases . The authors declare that the study sponsor had no role in the study design, collection, analysis, interpretation of data, writing of the manuscript, nor decision to submit the manuscript for publication.
Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Introduction Mastectomy is the current standard surgical procedure for ipsilateral breast tumor recurrence (IBTR). However, there is little evidence about the prognostic impact of the surgical procedure (mastectomy versus repeat lumpectomy) for IBTR. Patients and methods A total of 271 consecutive patients who had histologically confirmed IBTR without distant metastases and underwent definitive surgery for IBTR between 1989 and 2008 were included from eight institutions in Japan. The impact of the surgical procedure for IBTR on distant disease-free survival (DDFS) and overall survival (OS) was evaluated using and multivariable proportional hazards regression and propensity score matching methods. Results Of the 271 patients, 149 patients (55%) underwent repeat lumpectomy and 122 patients (45%) underwent mastectomy after IBTR. The median follow-up period from definitive surgery for IBTR was 55 months. There was no difference in terms of DDFS and OS between repeat lumpectomy and mastectomy after IBTR, adjusted for various clinical and tumor characteristics. In addition, for the matched patient cohort, no difference in DDFS and OS was seen between the 2 groups. Conclusion In our study, both multivariate analysis and the propensity score matching method demonstrated that there was no difference in terms of DDFS and OS between repeat lumpectomy and mastectomy after IBTR. Further studies are warranted (UMIN-CTR number UMIN000008136).
AB - Introduction Mastectomy is the current standard surgical procedure for ipsilateral breast tumor recurrence (IBTR). However, there is little evidence about the prognostic impact of the surgical procedure (mastectomy versus repeat lumpectomy) for IBTR. Patients and methods A total of 271 consecutive patients who had histologically confirmed IBTR without distant metastases and underwent definitive surgery for IBTR between 1989 and 2008 were included from eight institutions in Japan. The impact of the surgical procedure for IBTR on distant disease-free survival (DDFS) and overall survival (OS) was evaluated using and multivariable proportional hazards regression and propensity score matching methods. Results Of the 271 patients, 149 patients (55%) underwent repeat lumpectomy and 122 patients (45%) underwent mastectomy after IBTR. The median follow-up period from definitive surgery for IBTR was 55 months. There was no difference in terms of DDFS and OS between repeat lumpectomy and mastectomy after IBTR, adjusted for various clinical and tumor characteristics. In addition, for the matched patient cohort, no difference in DDFS and OS was seen between the 2 groups. Conclusion In our study, both multivariate analysis and the propensity score matching method demonstrated that there was no difference in terms of DDFS and OS between repeat lumpectomy and mastectomy after IBTR. Further studies are warranted (UMIN-CTR number UMIN000008136).
KW - Breast cancer
KW - Breast-conserving surgery
KW - Ipsilateral breast tumor recurrence
KW - Mastectomy
KW - Propensity score
KW - Repeat lumpectomy
UR - http://www.scopus.com/inward/record.url?scp=84961210123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961210123&partnerID=8YFLogxK
U2 - 10.1016/j.ejso.2016.01.011
DO - 10.1016/j.ejso.2016.01.011
M3 - Article
C2 - 26853760
AN - SCOPUS:84961210123
SN - 0748-7983
VL - 42
SP - 474
EP - 480
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 4
ER -